跳至主要内容
临床试验/IRCT20090117001556N114
IRCT20090117001556N114招募中3 期

Folinic acid add on therapy to risperidone in symptoms of children with autism: a randomized double-blind placebo-controlled clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4 years 至 12 years(—)
性别
All

入选标准

  • DSM-5 clinical diagnosis of autistic disorder
  • Children between the ages of 4 and 12 years old
  • Presence of behavioral problems such as aggression, overactivity or repetitive behaviors (indication of treatment with risperidone)

排除标准

  • Presence of any active medical problem
  • Other psychiatric diagnosis except for mild to moderate Intellectual disability
  • Receiving any antipsychotic medications during past monthprior to the trial
  • Severe hepatic disease
  • History of allergy to risperidone and intolerance of it
  • History of seizure requiring change of antiepileptic dose during the last month
  • Seizure during the last 6 months

研究者

相似试验

Folinic acid in the treatment of autism spectrum... | 临床试验